logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    
Gilead Sciences Inc.

Gilead Sciences Inc. (GILD)

Follow

Details

Wall

Profile


Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Issuer Information

Exchange: NASDAQ
Market Cap: 85694490248
CEO: John C. Martin
Employees: 5000
Issuer Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
CIK: 882095
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturin (325414)
SIC: 2836
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 650 574-3000
Address: 333 Lakeside Drive
Address 2:
State: CA
City / Town: Foster City
Country: USA
Postal Code: 94404
Fax:

Videos

No public videos available.

Blog

No Result Found.

News

Stock in health insurers is broadly down on Thursday morning. Every major health insurer saw shares down in early trading, with a disappointing earnings report from industry-leader UnitedHealth Group Inc.…
Just two days after the S&P 500 hit an all-time high, big sell-offs in biotech and tech took the market to its news, with the Nasdaq recording its worst day…
The race to produce the first effective Hepatitis C drug, and capture the massive profits that come with it, appears to have been won by Gilead Sciences (GILD) . At…
After soaring more than 56% last year, the NASDAQ Biotechnology Index is down almost 15% in March. In this interview with The Life Sciences Report, Jason Kolbert of the Maxim…
In another rough day of trading for American stocks, all three major indices lost more than a percentage point, with the Nasdaq leading the way with losses that briefly exceeded…
In early March, shares of Gilead ($GILD) notched a five-year-high of $84.88 per share thanks to the company’s Hepatitis C super drug Sovaldi. Costing $1,000 for a single tablet, Sovaldi…
While it’s still too early to tell, investors appear to be bailing on biotech stocks. Or, at least, they appear to be trying to make up their minds about it.…
Wall Street rallied early in Monday’s session, and maintained gains consistently throughout trading, with all indices once again approaching intraday highs to end the first quarter of 2014. Investors looking…
Henry Waxman (D-CA) has long been one of the more influential members of the House of Representatives, and he's also long been a thorn in the side to many on…
Veteran biotechnology analyst Michael King of JMP Securities has seen drug development evolve from hit-or-miss to the sophisticated, high-throughput discovery techniques in place today. He understands the sector, the entrepreneurs…

Trending

Social Mentions about your company in the last seven days
TennCare
24 Apr 14 01:21:29
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Brett
24 Apr 14 01:19:34
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
James Ambler
24 Apr 14 01:19:28
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Lyssa Phifer,
24 Apr 14 01:18:21
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Polish, .
24 Apr 14 01:16:47
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Anna
24 Apr 14 01:14:44
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
MarketNews
24 Apr 14 01:10:24
$GILD - Is there anything wrong with an $84,000 prescription drug? -> http://t.co/t0DgjC0Xhh #stock #stocks #stockaction
MarketNews
24 Apr 14 01:10:21
$GILD - Is there anything wrong with a $1,000 per day prescription drug? -> http://t.co/aZFxd5rENR #stock #stocks #stockaction
Tripti
24 Apr 14 01:09:33
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
mamabear
24 Apr 14 01:08:18
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
iHangout
24 Apr 14 01:07:00
chartguy89: Stock Charts: GILD 73.86 Stock Charts $GILD Gilead Sciences http://t.co/ZAQVYy28dk
Automated
24 Apr 14 01:06:56
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Michele Ciani
24 Apr 14 01:06:17
#biotech #buy #stocks $CYCC $EVOK $SPPI $ETRM $ALXA $PGNX $ADXS $GILD $MACK $IPCI $SGYP $NVAX $AGEN and others http://t.co/0zSuHNCSoX
PaulRMartin
24 Apr 14 01:06:10
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Joel van
24 Apr 14 01:03:38
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Jonelle
24 Apr 14 01:02:35
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
William Follmer
24 Apr 14 01:01:50
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
FirstWord Pharma
24 Apr 14 01:00:01
ViewPoints: Sovaldi redefines the blockbuster – how does the drug change Gilead Sciences' future? http://t.co/XoFwWiLaf8 $GILD
Blis of 47th
24 Apr 14 00:59:50
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
cjvezeau
24 Apr 14 00:58:40
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
chartguy89
24 Apr 14 00:58:21
GILD 73.86 Stock Charts $GILD Gilead Sciences Inc. (NASDAQ) Last Updated: 04/24/2014 02:58:20 GILD Stock Chart http://t.co/Ytpqa7i9wg
Justin
24 Apr 14 00:57:54
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
LoveStockNews
24 Apr 14 00:57:33
$GILD - Gilead (GILD) On Momo Momentum Watch Today -> http://t.co/AJTtDmitMi #stock #stocks #stockaction
Sean W.
24 Apr 14 00:56:10
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
LLM
24 Apr 14 00:55:52
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Jasmine
24 Apr 14 00:54:22
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Emily Barton
24 Apr 14 00:53:17
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Acquolina
24 Apr 14 00:53:02
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Chicago
24 Apr 14 00:51:29
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
USA Kids Eat
24 Apr 14 00:43:46
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Janine Burnham
24 Apr 14 00:42:08
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Kelly
24 Apr 14 00:41:40
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Texas Free
24 Apr 14 00:40:20
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Signs By Tomorrow
24 Apr 14 00:36:40
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Mila C
24 Apr 14 00:35:36
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Higher Level
24 Apr 14 00:34:13
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Chad
24 Apr 14 00:32:16
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
The Pancake
24 Apr 14 00:31:50
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Knippers
24 Apr 14 00:29:39
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
The Bliss
24 Apr 14 00:29:05
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Allen
24 Apr 14 00:26:25
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Matt
24 Apr 14 00:24:43
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Kevin Ackerman
24 Apr 14 00:23:33
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Hal
24 Apr 14 00:23:16
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Mabel
24 Apr 14 00:21:17
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
tasha
24 Apr 14 00:20:36
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Byrne Bray
24 Apr 14 00:20:04
$GILD AbbVie Files for HCV Combination Therapy in U.S. http://t.co/ZWvpFJAN0P
Enrique
24 Apr 14 00:19:36
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Danielle
24 Apr 14 00:19:04
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?
Blair Dempster
24 Apr 14 00:14:55
RT @MarkSchoenebaum: $GILD's $2.1B US Sovaldi number is above most "whispers" . . . will it matter?

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.